Report overview
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Molecular Diagnostics. This report contains market size and forecasts of Colorectal Cancer Molecular Diagnostics in global, including the following market information:
Global Colorectal Cancer Molecular Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Colorectal Cancer Molecular Diagnostics market was valued at US$ 617.9 million in 2022 and is projected to reach US$ 1504.1 million by 2029, at a CAGR of 13.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core colorectal cancer molecular diagnostics players include Roche Diagnostics, Abbott and Thermo Fisher etc. The top 3 companies hold a share about 45%. Middle East and Africa is the largest market with a share about 43%, followed by Asia-Pacific and Europe.
In terms of product, polymerase chain reaction PCR is the largest segment with a share about 50%. And in terms of applications, the largest application is third-party testing agency with a share about 48%.
We surveyed the Colorectal Cancer Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Colorectal Cancer Molecular Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Colorectal Cancer Molecular Diagnostics Market Segment Percentages, by Type, 2022 (%)
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Global Colorectal Cancer Molecular Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Colorectal Cancer Molecular Diagnostics Market Segment Percentages, by Application, 2022 (%)
Hospital
Third-Party Testing Agency
Others
Global Colorectal Cancer Molecular Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Colorectal Cancer Molecular Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Colorectal Cancer Molecular Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Colorectal Cancer Molecular Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche Diagnostics
Abbott
Thermo Fisher
Qiagen
Illumina
Biomerieux
Bio-Rad
Agilent
Daangene
Amoydx
Outline of Major Chapters:
Chapter 1: Introduces the definition of Colorectal Cancer Molecular Diagnostics, market overview.
Chapter 2: Global Colorectal Cancer Molecular Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Colorectal Cancer Molecular Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Colorectal Cancer Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
